CollPlant Biotechnologies Ltd (CLGN)

Nasdaq: CLGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Rehovot, IL · filing with the SEC since 2015

Full chart Alerts Compare

Grade5.1

◀ Past 4.9● Present 4.4▶ Future 6.4

2 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2025, as filed

Revenue$2.4M+360.4%

Net income-$11.5M+30.8%

Earnings per share$-0.94+35.2%

Operating cash flow-$9.4M+33.2%

Cash$5.6M-53.1%

Debtn/a

Shareholders’ equity$6.1M-54.8%

Shares, diluted12.2M+6.5%

Return on equity-188.9%

The recordfrom its filings

Filings in 202671

Newest filingNov 12 · 6-K

Annual reportMar 26, 2026

Quarterly reportn/a

Next report due20-F by Apr 30

Insider sales, 12 months$0.00

Insider buys, 12 months$0.00

Patents grantedn/a

Filer categoryNon-accelerated filer

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

1819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Nov 12, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Nov 5, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Nov 4, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Nov 3, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Nov 2, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 29, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 27, 2026 · SEC EDGAR · Form 144

Notice of intended sale

Open the filing on sec.gov

Oct 22, 2026 · SEC EDGAR · Form D

Private placement notice

Open the filing on sec.gov

Oct 19, 2026 · SEC EDGAR · Form 3

Insider holding, initial

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

CollPlant Biotechnologies Ltd is classed by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies (industry code 3842), based in Rehovot, IL.

Newest on the record

Interim report, foreign filer on Nov 12. Before it, interim report, foreign filer on Nov 12.

What is due next

The 20-F for the period to Dec 31, 2026, due by Apr 30, 2027.

About CLGN

CollPlant Biotechnologies Ltd is classed by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies (industry code 3842), based in Rehovot, IL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.4 million and a loss of $11 million (its filed statements).

IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

HeadquartersRehovot, IL

Business modelProduct business

ExchangeNasdaq

Filing since2015

Fiscal year endsDec 31

SEC number (CIK)1631487

Peers on fileCOCH, MLSS, RGNT, NTRB

Who runs it

Financial performance

In fiscal 2025 CollPlant Biotechnologies’s revenue was $2.37 million, up 360.4% from $515,000 the year before. It made a net loss of $11.49 million.

Annual report, filed Mar 26, 2026.

Financial statements

The grade

CollPlant Biotechnologies grades 5.1 of 10 against its own industry, the 29 companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies. Seven of the nine metrics are read as filed and two are SI estimates, each with its reasoning.

◀ Past4.9

● Present4.4

▶ Future6.4

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton CLGN · research, not advice